上皮中性粒細胞激活肽78(ENA78)多克隆抗體
Polyclonal Antibody to Epithelial Neutrophil Activating Peptide 78 (ENA78)
CXCL5; SCYB5; Chemokine C-X-C-Motif Ligand 5; Small Inducible Cytokine Subfamily B(Cys-X-Cys),Member 5; Neutrophil-activating peptide ENA-78
- 編號UPAA860Mu01
- 物種Mus musculus (Mouse，小鼠) 相同的名稱，不同的物種。
- 來源多抗制備
- 宿主兔
- 效價-
- Ig類型 IgG
- 純化方式抗原特異性親和純化
- 標記物無標記物
- 免疫原 RPA860Mu01-上皮中性粒細胞激活肽78(ENA78)重組蛋白
- 緩沖液成份0.01M 磷酸鹽緩沖液（pH7.4，containing 0.05% Proclin-300，50% glycerol）
- 性狀液體
- 濃度500μg/mL
- 且適物種-
- 應用WB; IHC; ICC; IP.
如果抗體需用于流式細胞術，請參見流式抗體。 - 下載 英文說明書 中文說明書
- 規(guī)格 20μl100μl 200μl 1ml 10ml
- 價格 ¥ 292 ¥ 680 ¥ 972 ¥ 2430 ¥ 9720
- 欲了解實際交易價格和更多情況，請與當?shù)亟?jīng)銷商聯(lián)系!
-
產品包裝(模擬)
-
產品包裝(模擬)
-
Used in DAB staining on fromalin fixed paraffin-embedded Stomach tissue
-
Figure. Western Blot; Sample: Recombinant ENA78, Mouse.
-
通過ISO 9001、ISO 13485質量體系認證
特異性
該抗體是針對ENA78的兔多克隆抗體。在免疫組織化學染色和免疫印跡實驗中能識別ENA78。
用法
Western blotting: 0.5-2μg/mL;
Immunohistochemistry: 5-20μg/mL;
Immunocytochemistry: 5-20μg/mL;
Optimal working dilutions must be determined by end user.
儲存
經(jīng)常使用則4°C保存。-20°C保存不超過兩年。避免反復凍融。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產生。保質期內，在適當?shù)臈l件下存儲，損失率低于5%。
贈品
增值服務
相關產品
| 編號 | 適用物種：Mus musculus (Mouse，小鼠) | 應用(僅供研究使用，不用于臨床診斷！) |
| UAPA860Mu02 | 上皮中性粒細胞激活肽78(ENA78)活性蛋白 | Cell?culture;?Activity?Assays. |
| URPA860Mu02 | 上皮中性粒細胞激活肽78(ENA78)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| UEPA860Mu61 | 上皮中性粒細胞激活肽78(ENA78)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| UEPA860Mu63 | 上皮中性粒細胞激活肽78(ENA78)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| UAPA860Mu61 | 上皮中性粒細胞激活肽78(ENA78)活性蛋白 | Cell?culture;?Activity?Assays. |
| URPA860Mu01 | 上皮中性粒細胞激活肽78(ENA78)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| UPAA860Mu02 | 上皮中性粒細胞激活肽78(ENA78)多克隆抗體 | IHC |
| UPAA860Mu01 | 上皮中性粒細胞激活肽78(ENA78)多克隆抗體 | WB; IHC; ICC; IP. |
| ULAA860Mu81 | 上皮中性粒細胞激活肽78(ENA78)多克隆抗體(異硫氰酸熒光素標記) | WB; IHC; ICC; IF. |
| ULAA860Mu71 | 上皮中性粒細胞激活肽78(ENA78)多克隆抗體(生物素標記) | WB; IHC; ICC. |
| USEA860Mu | 上皮中性粒細胞激活肽78(ENA78)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| UAEA860Mu | 抗上皮中性粒細胞激活肽78抗體(Anti-ENA78)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antibody Detection. |
| USCA860Mu | 上皮中性粒細胞激活肽78(ENA78)檢測試劑盒(化學發(fā)光免疫分析法) | Chemiluminescent immunoassay for Antigen Detection. |
| ULMA860Mu | 上皮中性粒細胞激活肽78(ENA78)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
| UKSA860Mu01 | 上皮中性粒細胞激活肽78(ENA78)檢測試劑盒DIY材料(酶聯(lián)免疫吸附試驗法) | 自己動手制作ELISA試劑盒的主要材料 |
參考文獻
| 雜志 | 參考文獻 |
| Journal of Biochemical and Molecular Toxicology | Ameliorative Effects of Curcumin on Fibrinogen-Like Protein-2 Gene Expression, Some Oxido-Inflammatory and Apoptotic Markers in a Rat Model of l-Arginine-Induced Acute Pancreatitis. [Pubmed:26862043] |
| Journal of Biochemical and Molecular Toxicology | Ameliorative Effects of Curcumin on Fibrinogen-Like Protein-2 Gene Expression, Some Oxido-Inflammatory and Apoptotic Markers in a Rat Model of l-Arginine-Induced Acute Pancreatitis [pubmed:26862043] |
| OncoTargets and Therapy | The clinical significance of CXCL5 in non-small cell lung cancer. [pubmed:29200871] |
| Biochimie | Activated CXCL5-CXCR2 axis promotes the migration, invasion and EMT of papillary thyroid carcinoma cells via modulation of β-catenin pathway [Pubmed:29471001] |
| Cancer?Biology?&?Therapy | Activation of CXCL5-CXCR2 axis promotes proliferation and accelerates G1 to S phase transition of papillary thyroid carcinoma cells and activates JNK and p38?… [Pubmed: 30404567] |
| Respiratory?Research | Phospholipase Cε plays a crucial role in neutrophilic inflammation accompanying acute lung injury through augmentation of CXC chemokine production from?… [Pubmed: 30634975] |
| American Journal of Pathology | Interleukin17–CXCR2 axis facilitates breast cancer progression by up-regulating neutrophil recruitment [Pubmed: 31654638] |
| Bioactive Materials | Secretions from hypochlorous acid-treated tumor cells delivered in a melittin hydrogel potentiate cancer immunotherapy [34820587] |
| Am J Cancer Res | Differential expression profile of CXC-receptor-2 ligands as potential biomarkers in pancreatic ductal adenocarcinoma [Pubmed:35141005] |
留言咨詢
